Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3655792

Cc1cc([N+]2(C3CCNC3)CCCC2C)ccc1NC(=O)c1ccc(C#N)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MLYCD O95822 1/20 0.37
P2RY14 Q15391 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
CTNNB1 P35222 3/20 0.35
BCL9 O00512 2/20 0.35
ESR1 P03372 1/20 0.34
TCF7L2 Q9NQB0 1/20 0.34
DPP4 P27487 1/20 0.34
MAPKAPK2 P49137 1/20 0.33
CSF1R P07333 1/20 0.33
CYP2C9 P11712 1/20 0.33
FASN P49327 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3657254 0.94 SMN1; SMN2 (0.39) MAPTRAB9ASMN1; SMN2P2RY14CTNNB1
Trifluoroacetic Acid SCHEMBL3657528 0.92 RXFP1 (0.37) RAB9AMLYCDP2RY14RXFP1CTNNB1
Trifluoroacetic Acid SCHEMBL3655804 0.91 CYP1A2 (0.36) RAB9A
SCHEMBL3651913 0.86 BCL9 (0.41) MAPTRAB9ASMN1; SMN2CTNNB1BCL9
SCHEMBL3658188 0.86 BCL9 (0.41) MAPTRAB9ASMN1; SMN2CTNNB1BCL9
SCHEMBL3653649 0.86 BCL9 (0.41) MAPTRAB9ASMN1; SMN2CTNNB1BCL9
Trifluoroacetic Acid SCHEMBL3656237 0.85 MLYCD (0.41) RAB9AMLYCDP2RY14CTNNB1BCL9
Trifluoroacetic Acid SCHEMBL3657613 0.83 SMN1; SMN2 (0.47) MAPTRAB9ASMN1; SMN2CYP2C9
SCHEMBL3654285 0.83 MAPT (0.38) MAPTRAB9ASMN1; SMN2P2RY14
SCHEMBL3648133 0.82 LMNA (0.41) MAPTRAB9ASMN1; SMN2CTNNB1BCL9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212282-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2010-08-04 EP disclosed
WO-2009052065-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-04-23 WO disclosed